跳至主要内容
临床试验/NL-OMON27278
NL-OMON27278已完成不适用

Interferon induction followed by PEG-interferon combined with ribavirin and amantadine for treatment of naive chronic hepatitis C patients with genotype 1 or 4;Pilot study to establish if initial drop in viral load is predictive for sustained virological response.

AMC Liver Center, Department GastroAcademic Medical Center, University of Amsterdam0 个研究点目标入组 58 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
58

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients which are serum HCV-RNA positive by PCR and with genotype 1 or 4;
  • 2. Patients who never have used antiviral therapy for chronic hepatitis C;

排除标准

  • 1. Patients who are pregnant and patients (male or female) who are not willing to practice adequate contraception during the treatment period and up to 6 months after ending the treatment period;
  • 2. Patients who are HBsAg or HIV antibody positive or who are unwilling to have these tests done;

研究者

发起方
AMC Liver Center, Department GastroAcademic Medical Center, University of Amsterdam

相似试验